Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Non-cash Items (2023 - 2025)

IceCure Medical (ICCM) reported Non-cash Items of $3.0 million for Q4 2025, up 2947.02% year-over-year from $100000.0 in Q4 2024, and up 2947.02% on a QoQ basis from $100000.0 in Q4 2024.

IceCure Medical (ICCM) has 3 years of Non-cash Items data on file, last reported at $3.0 million in Q4 2025.

  • Quarterly Non-cash Items rose 2947.02% year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (up 2947.02% YoY) and the FY2025 annual result came in at $3.0 million, up 28.63% from the prior year.
  • Non-cash Items rose to $3.0 million in Q4 2025 per ICCM's latest filing, from $100000.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $3.0 million in Q4 2025 and bottomed at $100000.0 in Q4 2024.
  • The 3-year median for Non-cash Items is $1.6 million (2023), against an average of $1.6 million.
  • The widest annual swing landed in 2024, when Non-cash Items slumped 93.71%; it then soared 2947.02% in 2025.
  • Tracing ICCM's Non-cash Items over 3 years: stood at $1.6 million in 2023, then plunged by 93.71% to $100000.0 in 2024, then soared by 2947.02% to $3.0 million in 2025.
  • Per Business Quant, the three latest ICCM Non-cash Items figures stand at $3.0 million (Q4 2025), $100000.0 (Q4 2024), and $1.6 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 IceCure Medical 12.09 -8.11 Mn 295,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.05 Mn
Dec 31, 2025 3.05 Mn
Dec 31, 2024 100,000.00
Dec 31, 2024 100,000.00
Dec 31, 2023 92,000.00
Dec 31, 2023 92,000.00